Commercial space flight giant SpaceX has warned investors it could face supply chain risks as it moves to scale up its in-house AI compute efforts.
Supply Risks Plague SpaceX
According to S-1 filings accessed by Reuters on Wednesday, SpaceX had listed its in-house chip manufacturing as one of its “substantial capital expenditures.” SpaceX also outlined that it did not have long-term contracts in place with suppliers and that it will continue to source a “significant” portion of its compute from third-party suppliers.
“There can be no assurance that we will be able to achieve our objectives with respect to TERAFAB within the expected timeframes, or at all,” SpaceX said.
data-variant=”card”
data-news-mode=”manual”
>
Read Also:
Environmental Group To Protest At Starbase As Investors Visit SpaceX Ahead Of IPO
This post was originally published here
